Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Tecentriq® (atezolizumab) and Tecentriq Hybreza® ...

The FDA has approved atezolizumab and atezolizumab with hyaluronidase-tqjs as adjuvant treatment for certain adults with ...

Roche RHHBY announced that the FDA has approved a label expansion for Tecentriq (atezolizumab) and Tecentriq Hybreza ...

VYVGART and VYVGART Hytrulo are the first and only approved treatments for all serotypes of adult patients living with gMG – anti-AChR-Ab ...

India has gained access to two new medicines: one targets a brain disease that's surging with the nation's ageing population; ...

Roche has launched a subcutaneous version of Tecentriq in India for eligible lung cancer patients. The approval could shorten hospital visits and sharpen the focus on convenience in cancer care.

Taking iron on an empty stomach may improve absorption of iron, but it can also increase your risk of certain side effects.

The regulatory document also lists any medical event experienced by a person during the study period between December 2020, ...

Ivermectin oral tablet is a generic medication used to treat intestinal strongyloidiasis and onchocerciasis affecting the eyes and skin. Common side effects include itching, diarrhea, nausea, ...

Creon (pancrelipase) is a prescription drug used to treat pancreatic insufficiency. Creon contains the active ingredient pancrelipase and comes as an oral delayed-release capsule. (This type of ...

The U.S. Food and Drug Administration has approved a label expansion for Vyvgart (efgartigimod alfa-fcab) and Vyvgart Hytrulo ...

Some of Gemtesa’s more common side effects include headache, nausea, diarrhea, and some infections. Serious side effects of Gemtesa aren’t common. They can include difficulty emptying your bladder, ...